Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan

BACKGROUND: Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial effect of tolvaptan. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujioka, Kensuke, Mizuno, Sumio, Ichise, Taro, Matsui, Takao, Hirase, Hiroaki, Yamaguchi, Masato, Aoyama, Takahiko, Yamagishi, Masakazu, Fujino, Noboru, Kawashiri, Masa-aki, Hayashi, Kenshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348497/
https://www.ncbi.nlm.nih.gov/pubmed/30803403
http://dx.doi.org/10.1177/1753944718819064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348497/
https://www.ncbi.nlm.nih.gov/pubmed/30803403
http://dx.doi.org/10.1177/1753944718819064

Ejemplares similares